Ship Healthcare Holdings, Inc.

3360.T
Medical Instruments & Supplies
2026/03/06 Updated
Market Cap: $1.5B (¥233.2B)
Stock Price: $16.09 (¥2,534)
Exchange Rate: 1 USD = ¥157.48

Notice Regarding Changes in Representative Directors and Officers

There will be a change in the representative director effective April 1, 2026, and a proposal for election of directors will be submitted at the Annual General Meeting of Shareholders scheduled for June 25, 2026. Appointment of new directors and executive officers has been announced.

Importance:
Page Updated: March 6, 2026
IR Disclosure Date: March 6, 2026

Key Figures

  • Scheduled Date of Representative Director Change: 2026年4月1日
  • Scheduled Date of Annual General Meeting of Shareholders: 2026年6月25日
  • Directors Scheduled to Resign: Kenzo Konishi (As of 2026年6月25日)

AI要約

Overview of Changes in Representative Directors and Officers

Ship Healthcare Holdings, Ltd. has resolved to implement a change in representative directors effective April 1, 2026. The reason for the change is personal circumstances. Furthermore, a proposal for election of directors will be submitted at the Annual General Meeting of Shareholders scheduled for June 25, 2026, where new directors and executive officers are expected to assume their positions. Mr. Kenzo Konishi is scheduled to resign as director on the same date.

Profiles of New Officers and Future Management Structure

Ms. Yuki Uchiyama, a new director candidate, has extensive experience in law firms and as an outside director, while Mr. Minoru Shinyama, a new executive officer, has experience as sales manager of the medical-related business division. The officer structure will be finalized following approval at the Annual General Meeting of Shareholders, with Mr. Kunihisa Furukawa as Representative Director Chairman and Mr. Futoshi Ohashi as Representative Director President playing central roles. This aims to strengthen the management system.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.